Lionne D. F. Venderbos
Papers
3
Total Citations
45
H-Index
3
About
Lionne D. F. Venderbos is a leading clinical researcher in uro-oncology, specializing in prostate cancer treatment outcomes and patient quality of life. Her work centers on optimizing surgical techniques and decision-making for men with prostate cancer, particularly through nerve-sparing radical prostatectomy and active surveillance. Dr. Venderbos made significant contributions by investigating the NeuroSAFE technique, which uses intraoperative frozen section analysis to preserve neurovascular bundles during surgery. Her 2023 study on this topic (22 citations) demonstrated improved urinary continence and sexual function outcomes, directly influencing surgical practice. She also addressed the critical question of whether delayed radical treatment after active surveillance harms quality of life—her 2014 study (17 citations) found that men who deferred surgery did not experience worse functional outcomes, reassuring patients and clinicians. Additionally, her research on lymphoceles after pelvic lymph node dissection (2023, 6 citations) provides practical insights into postoperative complications. With a growing citation record and a focus on patient-centered outcomes, Dr. Venderbos is shaping evidence-based urological care, helping men with prostate cancer make informed choices that balance cancer control with quality of life.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3